Skip to main content
Live

Market Intelligence

Page 877

Stocks·dow-jones

Dow 50,000: Market Euphoria or the Last Hurrah Before a Reality Check for Blue Chips?

Feb 8, 2026·8m
Stocks·sp500-equal-weight

S&P 500 Equal Weight Index Hits New High: Rotation Mania or the Real Market Signal?

Feb 8, 2026·8m
Crypto·ethereum

Ethereum’s Liquidity Squeeze: Why Multi-Year Reserve Lows Could Fuel a Snapback Rally

Feb 8, 2026·8m
Forex·eurusd

Euro’s Quiet Defiance: Why EURUSD’s $1.182 Is a Powder Keg in the Making for Macro Traders

Feb 8, 2026·8m
Forex·usdjpy

Yen’s Great Sleepwalk: Why USDJPY’s 157.18 Stalemate Is a Volatility Trap Waiting to Snap

Feb 8, 2026·8m
Macro·cpi

Tariffs, CPI, and the Great Macro Mirage: Why Inflation Risks Are Just Getting Started

Feb 8, 2026·8m
Stocks·ai

Big Tech’s $650 Billion AI Binge Splinters Wall Street: Rotation or Reckoning?

Feb 8, 2026·8m
Commodities·commodities

Commodities in Suspended Animation: Why DBC’s Flatline Is the Macro Market’s Loudest Signal

Feb 8, 2026·8m
Stocks·xlk

Tech Sector Flatlines as AI Fatigue and Rotation to Value Leave XLK in a Holding Pattern

Feb 8, 2026·8m
Crypto·bitcoin

Bitcoin’s Conviction Zone: Why Smart Money Is Waiting While Retail Nerves Fray

Feb 8, 2026·8m
Stocks·ai

AI’s $650 Billion Hangover: Why Tech’s Spending Binge Is Fueling a Market Identity Crisis

Feb 8, 2026·8m
Crypto·xrp

XRP’s Five-Year Surge: Can the Comeback King Outrun Crypto’s Bear Market Blues?

Feb 8, 2026·8m
Forex·dollar-index

Dollar Index Stalls at $97.68 as FX Volatility Flatlines: Is the Calm Before the Storm Over?

Feb 8, 2026·8m
Stocks·pharma

Big Pharma’s Obesity Wars: How Eli Lilly and Novo Nordisk Are Reshaping the Earnings Playbook

Feb 8, 2026·8m
Crypto·solana

Solana’s Comeback Quest: Can the Once-Hot Blockchain Reclaim Its All-Time High After the Crash?

Feb 8, 2026·8m